Blau Farmacêutica S.A. (BVMF: BLAU3)

Blau Farmacêutica Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	20.71	31.5	14.11	51.86	70.2	6.42
Short-Term Investments	-	375.82	629.53	870.96	144.15	152.65
Cash & Short-Term Investments	431.95	407.31	643.65	922.82	214.35	159.06
Cash Growth	-8.47%	-36.72%	-30.25%	330.52%	34.76%	40.83%
Accounts Receivable	504.28	453.56	420.61	331.79	247.55	140.82
Other Receivables	97.59	64.35	44.58	13.66	9.22	13.71
Receivables	601.87	517.91	465.19	345.45	256.78	154.52
Inventory	552.09	628.65	569.02	416.85	327.49	187.57
Other Current Assets	-	-	-	11.35	1.88	-
Total Current Assets	1,586	1,554	1,678	1,696	800.5	501.16
Property, Plant & Equipment	800.35	738.71	542.48	371.58	244.05	154.65
Long-Term Investments	265.16	265.19	-	0.04	0.03	0.03
Goodwill	151.66	151.66	143.24	143.24	144.64	7.07
Other Intangible Assets	48.52	24.83	16.57	5.75	3.48	3
Long-Term Deferred Tax Assets	89.8	81.53	-	-	15.87	9.48
Long-Term Deferred Charges	246.86	177.58	74.25	49.82	21.64	11.32
Other Long-Term Assets	53.25	60.17	44.65	61.14	42.43	51.75
Total Assets	3,241	3,054	2,499	2,328	1,273	738.44
Accounts Payable	219.46	179.92	163.64	116.43	133	85.24
Accrued Expenses	112.24	55.62	56.78	55.2	42.16	18.27
Short-Term Debt	1.38	2.3	-	41.73	15.81	-
Current Portion of Long-Term Debt	58.45	67.92	79.87	49.82	47.01	74.83
Current Portion of Leases	6.17	4.8	3.67	2.11	1.44	-
Current Income Taxes Payable	15.75	-	19.44	19.99	36.23	21.01
Other Current Liabilities	42.37	25.38	47.71	57.72	88.19	63.23
Total Current Liabilities	455.8	335.93	371.11	343.01	363.83	262.57
Long-Term Debt	450	500	200	272.5	626.33	203.89
Long-Term Leases	33.52	33.52	28.17	8.35	0.38	0.21
Long-Term Deferred Tax Liabilities	153.3	125.64	35.02	18.25	-	-
Other Long-Term Liabilities	64.19	63.2	46.81	51.05	60.74	6.02
Total Liabilities	1,157	1,058	681.11	693.16	1,051	472.69
Common Stock	1,317	1,317	1,317	1,317	100.64	100.64
Retained Earnings	841.49	744.37	562.8	325.13	84.64	163.34
Treasury Stock	-42.89	-42.89	-39.9	-	-	-
Comprehensive Income & Other	-18	-16.62	-17.36	-5.45	36.07	1.78
Total Common Equity	2,097	2,001	1,822	1,636	221.34	265.76
Minority Interest	-12.52	-6.22	-4.22	-1.4	-	-
Shareholders' Equity	2,085	1,995	1,818	1,635	221.34	265.76
Total Liabilities & Equity	3,241	3,054	2,499	2,328	1,273	738.44
Total Debt	549.51	608.54	311.71	374.52	690.96	278.92
Net Cash (Debt)	-117.57	-201.22	331.93	548.3	-476.61	-119.86
Net Cash Growth	-	-	-39.46%	-	-	-
Net Cash Per Share	-0.66	-1.13	1.87	3.06	-3.02	-0.79
Filing Date Shares Outstanding	177.68	177.68	177.83	179.39	148	148
Total Common Shares Outstanding	177.68	177.68	177.83	179.39	148	148
Working Capital	1,130	1,218	1,307	1,353	436.67	238.59
Book Value Per Share	11.80	11.26	10.25	9.12	1.50	1.80
Tangible Book Value	1,897	1,825	1,662	1,487	73.22	255.69
Tangible Book Value Per Share	10.68	10.27	9.35	8.29	0.49	1.73
Machinery	-	302.14	170.92	135.22	121.52	86.89
Construction In Progress	-	257.03	210.19	194.06	84.28	69.08

Source: S&P Capital IQ. Standard template. Financial Sources.